Kinetic Model Development

Kinetic model development employs mathematical frameworks quantitating drug absorption, distribution, metabolism, and excretion. Compartmental models assume uniform concentration within compartments. Non-compartmental analysis avoids model assumptions. Physiologically-based models incorporate organ-specific anatomy. Bayesian forecasting predicts individual patient exposures.

Regulatory submissions employ kinetic modelling supporting dose recommendations. Population pharmacokinetics quantitate variability across patients. Model validation confirms predictive accuracy. Emerging machine learning enhances model development. Post-approval monitoring refines model parameters.